Literature DB >> 7730401

Insulin-sensitive targeting of the GLUT4 glucose transporter in L6 myoblasts is conferred by its COOH-terminal cytoplasmic tail.

P M Haney1, M A Levy, M S Strube, M Mueckler.   

Abstract

The GLUT4 glucose transporter appears to be targeted to a unique insulin-sensitive intracellular membrane compartment in fat and muscle cells. Insulin stimulates glucose transport in these cell types by mediating the partial redistribution of GLUT4 from this intracellular compartment to the plasma membrane. The structural basis for the unique targeting behavior of GLUT4 was investigated in the insulin-sensitive L6 myoblast cell line. Analysis of immunogold-labeled cells of independent clonal lines by electron microscopy indicated that 51-53% of GLUT1 was present in the plasma membrane in the basal state. Insulin did not significantly affect this distribution. In contrast, only 4.2-6.1% of GLUT4 was present in the plasma membrane of basal L6 cells and insulin increased this percentage by 3.7-6.1-fold. Under basal conditions and after insulin treatment, GLUT4 was detected in tubulovesicular structures, often clustered near Golgi stacks, and in endosome-like vesicles. Analysis of 25 chimeric transporters consisting of reciprocal domains of GLUT1 and GLUT4 by confocal immunofluorescence microscopy indicated that only the final 25 amino acids of the COOH-terminal cytoplasmic tail of GLUT4 were both necessary and sufficient for the targeting pattern observed for GLUT4. A dileucine motif present in the COOH-terminal tail of GLUT4 was found to be necessary, but not sufficient, for intracellular targeting. Contrary to previous studies, the NH2 terminus of GLUT4 did not affect the subcellular distribution of chimeras. Analysis of a chimera containing the COOH-terminal tail of GLUT4 by immunogold electron microscopy indicated that its subcellular distribution in basal cells was very similar to that of wild-type GLUT4 and that its content in the plasma membrane increased 6.8-10.5-fold in the presence of insulin. Furthermore, only the chimera containing the COOH terminus of GLUT4 enhanced insulin responsive 2-deoxyglucose uptake. GLUT1 and two other chimeras lacking the COOH terminus of GLUT4 were studied by immunogold electron microscopy and did not demonstrate insulin-mediated changes in subcellular distribution. The NH2-terminal cytoplasmic tail of GLUT4 did not confer intracellular sequestration and did not cause altered subcellular distribution in the presence of insulin. Intracellular targeting of one chimera to non-insulin-sensitive compartments was also observed. We conclude that the COOH terminus of GLUT4 is both necessary and sufficient to confer insulin-sensitive subcellular targeting of chimeric glucose transporters in L6 myoblasts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7730401      PMCID: PMC2120453          DOI: 10.1083/jcb.129.3.641

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  61 in total

1.  A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains.

Authors:  F Letourneur; R D Klausner
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  A glucose transport protein expressed predominately in insulin-responsive tissues.

Authors:  M J Charron; F C Brosius; S L Alper; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.

Authors:  H Fukumoto; T Kayano; J B Buse; Y Edwards; P F Pilch; G I Bell; S Seino
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

4.  Peptide-specific antibodies as probes of the orientation of the glucose transporter in the human erythrocyte membrane.

Authors:  A Davies; K Meeran; M T Cairns; S A Baldwin
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

5.  Construction of mutant and chimeric genes using the polymerase chain reaction.

Authors:  F Vallette; E Mege; A Reiss; M Adesnik
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

6.  On the preparation of cryosections for immunocytochemistry.

Authors:  G Griffiths; A McDowall; R Back; J Dubochet
Journal:  J Ultrastruct Res       Date:  1984-10

7.  Sequence and structure of a human glucose transporter.

Authors:  M Mueckler; C Caruso; S A Baldwin; M Panico; I Blench; H R Morris; W J Allard; G E Lienhard; H F Lodish
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

8.  Insulin action in denervated rat hemidiaphragms. Decreased hormonal stimulation of glycogen synthesis involves both glycogen synthase and glucose transport.

Authors:  R L Smith; J C Lawrence
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

9.  Identification of a novel gene encoding an insulin-responsive glucose transporter protein.

Authors:  M J Birnbaum
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

10.  Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.

Authors:  K H Kaestner; R J Christy; J C McLenithan; L T Braiterman; P Cornelius; P H Pekala; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more
  17 in total

1.  The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells.

Authors:  F Giorgino; O de Robertis; L Laviola; C Montrone; S Perrini; K C McCowen; R J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  The cytosolic C-terminus of the glucose transporter GLUT4 contains an acidic cluster endosomal targeting motif distal to the dileucine signal.

Authors:  A M Shewan; B J Marsh; D R Melvin; S Martin; G W Gould; D E James
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

3.  Insulin resistance and the disruption of Glut4 trafficking in skeletal muscle.

Authors:  M Mueckler
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 4.  Thirty sweet years of GLUT4.

Authors:  Amira Klip; Timothy E McGraw; David E James
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

5.  Arrest of endosome acidification by bafilomycin A1 mimics insulin action on GLUT4 translocation in 3T3-L1 adipocytes.

Authors:  S R Chinni; A Shisheva
Journal:  Biochem J       Date:  1999-05-01       Impact factor: 3.857

6.  The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.

Authors:  H H Gu; X Wu; B Giros; M G Caron; M J Caplan; G Rudnick
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

7.  p115 Interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation.

Authors:  Toshio Hosaka; Cydney C Brooks; Eleonora Presman; Suk-Kyeong Kim; Zidong Zhang; Michael Breen; Danielle N Gross; Elizabeth Sztul; Paul F Pilch
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

8.  Assembly and preferential localization of Nup116p on the cytoplasmic face of the nuclear pore complex by interaction with Nup82p.

Authors:  A K Ho; T X Shen; K J Ryan; E Kiseleva; M A Levy; T D Allen; S R Wente
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

9.  Subcellular trafficking kinetics of GLU4 mutated at the N- and C-terminal.

Authors:  S Araki; J Yang; M Hashiramoto; Y Tamori; M Kasuga; G D Holman
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

10.  The C-terminus of GLUT4 targets the transporter to the perinuclear compartment but not to the insulin-responsive vesicles.

Authors:  Lin V Li; Kyriaki Bakirtzi; Robert T Watson; Jeffrey E Pessin; Konstantin V Kandror
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.